oncology portfolio

Actionable Insights Powered by AI

AstraZeneca Beats Q2 Estimates on Strong Cancer Drug Sales

AstraZeneca; Q2 2025; cancer drug sales; oncology portfolio; Tagrisso; Imfinzi; Enhertu; financial results